A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis. [electronic resource]
Producer: 20040521Description: 257-64 p. digitalISSN:- 0269-9370
- AIDS-Related Opportunistic Infections -- complications
- Adjuvants, Immunologic -- administration & dosage
- Administration, Cutaneous
- Adolescent
- Adult
- Antitubercular Agents -- administration & dosage
- CD4 Lymphocyte Count
- Etanercept
- Female
- HIV-1
- Humans
- Immunoglobulin G -- administration & dosage
- Male
- Middle Aged
- Mycobacterium tuberculosis -- isolation & purification
- Radiography
- Receptors, Tumor Necrosis Factor -- administration & dosage
- Sputum -- chemistry
- Tuberculosis -- complications
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.